Johnson & Johnson to contribute a further $1 billion to US opioid settlement
October 14, 2020Research and Development, Sales and Marketing J&J, JJ, opioid crisis, opioids, pharma
Johnson & Johnson will pay another $1 billion to settle lawsuits alleging it fuelled the opioid crisis in the US. …
Pharmafile.com’s weekly COVID-19 news round-up
October 14, 2020Research and Development COVID-19, coronavirus, covid news, pandemic, weekly roundup
The COVID-19 news this week focuses on FDA authorisations, with Eli Lilly seeking Emergency Use Authorization (EUA) from the FDA …
Man in US contracts COVID-19 for the second time with worse symptoms
October 13, 2020Manufacturing and Production COVID, coronavirus
An American man has caught coronavirus for the second time, with the second infection being far more dangerous than the …
J&J halts COVID-19 vaccine study following unidentified participant illness
October 13, 2020Manufacturing and Production, Research and Development COVID-19, J&J, JJ, Vaccine, pharma
Johnson & Johnson has announced its decision to slam the brakes on the development programme for its COVID-19 vaccine following …
Head of WHO says herd immunity strategies for COVID-19 are ‘unethical’
October 13, 2020Manufacturing and Production
Tedros Adhanom Ghebreyesus, Director of the World Health Organization, has warned against pursuing a strategy of herd immunity to fight …
Bavencio/axitinib combo approved for NHS Scotland in advanced renal cell carcinoma
October 13, 2020Manufacturing and Production, Sales and Marketing Merck, NHS, Pfizer, SMC
The Scottish Medicines Consortium (SMC) has given the go-ahead to Merck KGaA and Pfizer’s combination of their PD-L1 inhibitor immunotherapy …
UK Government ignored SAGE advice to impose full lockdown last month
October 13, 2020Manufacturing and Production COVID, UK, UK Coronavirus, coronavirus
UK Government ministers ignored warnings three weeks ago that the country should go into a temporary full lockdown to reduce …
University of Glasgow research details promising precision medicine approach in pancreatic cancer
October 12, 2020Research and Development, Sales and Marketing Cancer, Precision Medicine
Researchers at the University of Glasgow have unveiled a new precision medicine approach to identify and pair pancreatic cancer patients …
China to test entire population of Qingdao over nine days
October 12, 2020Sales and Marketing coivd-19, coronavirus, pandemic, virus
China plans to test the entire city of Qingdao, containing nine million people, for coronavirus over a period of five …
Pharmaceutical industry donating more to Democrats than Republicans in the lead up to 2020 election
October 12, 2020Sales and Marketing
The long-term trend of the pharmaceutical industry largely donating to the US Republican Party has been reversed in the lead …
New Zealand Government signs deal with Pfizer and BioNTech for 1.5 million COVID-19 vaccines
October 12, 2020Sales and Marketing
The New Zealand Government has signed a deal with Pfizer and BioNTech for one of their promising COVID-19 vaccine candidates. …
Sun Pharma issues recall of its generic diabetes drug in US market
October 12, 2020Sales and Marketing FDA, diabetes, recall
Sun Pharma is recalling 747 bottles of its generic diabetes drug Riomet ER in the US.This is due to an …
Dr Kevin Eggan named as Group Vice President, Head of Research and Early Development at BioMarin
October 9, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Kevin Eggan, appointments
BioMarin Pharmaceutical has welcomed Dr Kevin Eggan as its new Group Vice President, Head of Research and Early Development. He …
Dr Sarah Noonberg appointed Chief Medical Officer of Maze Therapeutics
October 9, 2020Medical Communications
Maze Therapeutics has appointed Dr Sarah Noonberg as its Chief Financial Officer. Noonberg is a physician-scientist with expertise in global …
Takeda and Arrowhead Pharma join forces in $1m rare liver disease drug development pact
October 9, 2020Medical Communications, Research and Development Arrowhead, Takeda, pharma
A new partnership has been struck between Takeda and Arrowhead Pharmaceuticals, with both companies coming together to co-develop and license …
Amgen and Cytokinetics’ drug falls short in heart failure despite hitting primary goal
October 9, 2020Medical Communications Amgen, cytokines, heart failure, pharma
New Phase 3 data has come to light on Amgen and Cytokinetics’ cardiac myosin activator therapy omecamtiv mecarbil fell short …
US Supreme Court refuses Trump administration’s request to restrict delivery of abortion medication
October 9, 2020Medical Communications abortion, abortion pill
The US Supreme Court has struck down a request from the Trump administration to restrict delivery of abortion medicine during …
European Commission agrees deal with Janssen for 200 million doses of its COVID-19 vaccine
October 9, 2020Medical Communications AZ, AstraZeneca, Janssen
The European Commission has approved an agreement with Johnson & Johnson for the supply of 200 million doses of Janssen’s …
Top Ten most popular articles on Pharmafile.com this week
October 9, 2020Medical Communications coronavirus, news
The top ten news stories this week focus on clinical trial data, as Amgen and Novartis have revealed new five-year …
Allergan R&D Chief named as Chairman of Exscientia’s Board of Directors
October 8, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, Exscientia, appointment
Artificial intelligence-driven drug discovery firm Exscientia has named industry veteran Dr David Nicholson, current Executive Vice President and Chief R&D …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
